comprehensive -WSS

comprehensive

author：hotspot 2025-09-06 03:55:15 - browse：34

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Medicare Advantage 2025 payments will dip, Biden administration says

entertainment

WSS

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Xenotransplantation trials will require adjusting expectations, experts say

Novo pauses ads for weight loss drug Wegovy amid demand

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Multiple sclerosis has subtypes with different best treatments: study

entertainment

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

Harvard scientists, with Google, unveil the most detailed brain map ever

Malaria cases in Florida and Texas: Here’s what you need to know

Bird flu in dairy cattle: New measures to control spread to humans

Bright Health sells Medicare Advantage business to Molina

Overprescribed: High cost isn't America's only drug problem

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

U.K. decision on ALS drug has neurologists, advocates up in arms

After affirmative action ruling, medical educators look to 'holistic review'

Scientists uncover potential path to treating deadly childhood tumor

Wikipedia

First Opinion on colorectal cancer screening: letter and response

Researchers test human milk's ability to repair gut microbiome

People with mental disorders often marry others with same

Study: Black kids more likely to die after surgery than white kids

Living organ donors deserve priority status for transplants

Biogen nominates mother of director’s child to replace him on board

hotspot

leisure time

entertainment

focus